Rebecca R. Saff, Ph.D.
Affiliations: | 2004 | Boston University, Boston, MA, United States |
Area:
ImmunologyGoogle:
"Rebecca Saff"Parents
Sign in to add mentor| Ann Marshak-Rothstein | grad student | 2004 | Boston University | |
| (The role of Fas ligand in tumor immunity.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gregory MS, Hackett CG, Abernathy EF, et al. (2011) Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death. Plos One. 6: e17659 |
| Gregory MS, Saff RR, Marshak-Rothstein A, et al. (2007) Control of ocular tumor growth and metastatic spread by soluble and membrane Fas ligand. Cancer Research. 67: 11951-8 |
| Gregory MS, Koh S, Huang E, et al. (2005) A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege. Investigative Ophthalmology & Visual Science. 46: 2495-502 |
| Saff RR, Spanjaard ES, Hohlbaum AM, et al. (2004) Activation-induced cell death limits effector function of CD4 tumor-specific T cells. Journal of Immunology (Baltimore, Md. : 1950). 172: 6598-606 |
| Gregory MS, Repp AC, Holhbaum AM, et al. (2002) Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. Journal of Immunology (Baltimore, Md. : 1950). 169: 2727-35 |
| Hohlbaum AM, Saff RR, Marshak-Rothstein A. (2002) Fas-ligand--iron fist or Achilles' heel? Clinical Immunology (Orlando, Fla.). 103: 1-6 |